Inventor · disambiguated record
Sheila Connelly
Also filed as: CONNELLY SHEILA
32 granted patents·10 pending applications·199 citations·filing 1995–2024
96Inventor score
Files withSYNTHETIC BIOLOGICS INC21THERIVA BIOLOGICS INC10SYNTHETIC BIOLOGIES INC4SYNTHETIC BIOLOG INC2GENETIC THERAPHY INC1
Top patents by PatentIndex Score
42 records- 0198US11608494B2Beta-lactamases with improved properties for therapyTHERIVA BIOLOGICS INC·Filed 2021·Granted Mar 21, 2023·2 cites·12 claims
- 0295US11236319B2Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2020·Granted Feb 1, 2022·2 cites·12 claims
- 0393US10767171B2Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2020·Granted Sep 8, 2020·2 cites·10 claims
- 0491US9744221B2Method and compositions for inhibiting or preventing adverse effects of oral antibioticsSYNTHETIC BIOLOGICS INC·Filed 2015·Granted Aug 29, 2017·3 cites·12 claims
- 0590US6608038B2Methods and compositions for treatment of diabetes and related conditions via gene therapyNOVARTIS AG·Filed 2001·Granted Aug 19, 2003·47 cites·8 claims
- 0689US5935935AAdenoviral vectors for treatment of hemophiliaGENETIC THERAPY INC·Filed 1995·Granted Aug 10, 1999·98 cites·65 claims
- 0788US2023313166A1Beta-lactamases with improved properties for therapyTHERIVA BIOLOGICS INC·Filed 2023·Application pending·0 cites
- 0887US12274740B2Microbiome protection from oral antibioticsTHERIVA BIOLOGICS INC·Filed 2023·Granted Apr 15, 2025·0 cites·20 claims
- 0987US10584326B2Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2019·Granted Mar 10, 2020·2 cites·18 claims
- 1087US10336995B2Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2018·Granted Jul 2, 2019·2 cites·12 claims
- 1187US2024197842A1Method and compositions for inhibiting or preventing adverse effects of oral antibioticsTHERIVA BIOLOGICS INC·Filed 2024·Application pending·0 cites
- 1286US11944669B2Method and compositions for inhibiting or preventing adverse effects of oral antibioticsTHERIVA BIOLOGICS INC·Filed 2023·Granted Apr 2, 2024·0 cites·19 claims
- 1386US10087433B1Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2018·Granted Oct 2, 2018·2 cites·18 claims
- 1486US10011824B2Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2017·Granted Jul 3, 2018·2 cites·31 claims
- 1586US9783797B1Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2017·Granted Oct 10, 2017·2 cites·32 claims
- 1686US9464280B1Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2016·Granted Oct 11, 2016·2 cites·25 claims
- 1786US9404103B1Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2016·Granted Aug 2, 2016·2 cites·29 claims
- 1885US10548955B2Carbapenemases for use with antibiotics for the protection of the intestinal microbiomeSYNTHETIC BIOLOGICS INC·Filed 2018·Granted Feb 4, 2020·3 cites·14 claims
- 1985US9695409B2Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2016·Granted Jul 4, 2017·2 cites·35 claims
- 2085US9376673B1Beta-lactamases with improved properties for therapySYNTHETIC BIOLOG INC·Filed 2016·Granted Jun 28, 2016·2 cites·29 claims
- 2185US9290754B2Beta-lactamases with improved properties for therapySYNTHETIC BIOLOG INC·Filed 2015·Granted Mar 22, 2016·2 cites·19 claims
- 2283US10046035B2Methods and compositions for inhibiting or preventing adverse effects of oral antibioticsSYNTHETIC BIOLOGICS INC·Filed 2017·Granted Aug 14, 2018·2 cites·12 claims
- 2379US11883474B2Microbiome protection from oral antibioticsTHERIVA BIOLOGICS INC·Filed 2022·Granted Jan 30, 2024·0 cites·22 claims
- 2476US11123413B2Carbapenemases for use with antibiotics for the protection of the intestinal microbiomeSYNTHETIC BIOLOGIES INC·Filed 2019·Granted Sep 21, 2021·0 cites·14 claims
- 2575US11654184B2Alkaline phosphatase agents for treatment of radiation disordersTHERIVA BIOLOGICS INC·Filed 2019·Granted May 23, 2023·1 cites·15 claims
- 2674US11596674B2Method and compositions for inhibiting or preventing adverse effects of oral antibioticsSYNTHETIC BIOLOGIES INC·Filed 2020·Granted Mar 7, 2023·0 cites·19 claims
- 2774US2022000991A1Carbapenemases for use with antibiotics for the protection of the intestinal microbiomeSYNTHETIC BIOLOGICS INC·Filed 2021·Application pending·0 cites
- 2873US10792346B2Method and compositions for inhibiting or preventing adverse effects of oral antibioticsSYNTHETIC BIOLOGICS INC·Filed 2018·Granted Oct 6, 2020·0 cites·16 claims
- 2973US2023398194A1Methods and compositions for attenuating antibiotic resistanceTHERIVA BIOLOGICS INC·Filed 2023·Application pending·0 cites
- 3071US12178917B2Beta-lactamase formulations and uses thereofTHERIVA BIOLOGICS INC·Filed 2020·Granted Dec 31, 2024·0 cites·16 claims
- 3170US10828260B2Beta-lactamase formulations and uses thereofSYNTHETIC BIOLOGICS INC·Filed 2018·Granted Nov 10, 2020·0 cites·12 claims
- 3269US2022241383A1Alkaline phosphatase agents for treatment of neurodevelopmental disordersSYNTHETIC BIOLOGICS INC·Filed 2022·Application pending·0 cites
- 3368US2023310558A1Alkaline phosphatase agents for treatment of radiation disordersTHERIVA BIOLOGICS INC·Filed 2023·Application pending·0 cites
- 3466US11517614B2Microbiome protection from oral antibioticsSYNTHETIC BIOLOGIES INC·Filed 2017·Granted Dec 6, 2022·0 cites·20 claims
- 3565US11338020B2Alkaline phosphatase agents for treatment of neurodevelopmental disordersSYNTHETIC BIOLOGIES INC·Filed 2019·Granted May 24, 2022·0 cites·18 claims
- 3665US6649375B2Adenoviral vectors for enhanced gene expressionGENETIC THERAPHY INC·Filed 1998·Granted Nov 18, 2003·18 cites·106 claims
- 3761US10105322B2Beta-lactamase formulations and uses thereofSYNTHETIC BIOLOGICS INC·Filed 2015·Granted Oct 23, 2018·0 cites·14 claims
- 3858US2019275120A1Methods and compositions for attenuating antibiotic resistanceSYNTHETIC BIOLOGICS INC·Filed 2017·Application pending·0 cites
- 3954US2016250304A1Carbapenemases for use with antibiotics for the protection of the intestinal microbiomeSYNTHETIC BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 4051US2022218800A1Beta-lactamase compositions for treatment of graft versus host diseaseSYNTHETIC BIOLOGICS INC·Filed 2020·Application pending·0 cites
- 4139US2003104625A1Novel oncolytic adenoviral vectorsFiled 2002·Application pending·0 cites
- 4230US6018103AChimeric plant genes possessing independent regulatory sequencesNOVARTIS FINANCE CORP·Filed 1995·Granted Jan 25, 2000·1 cites·45 claims
Join the waitlist — get patent alerts
Get an alert when Sheila Connelly files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →